Latest filing published 27 Oct 2022 for Enfusion, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Stephen M. Dorton: trading record in brief
Stephen M. Dorton, listed as finance chief, appears in our data through filings on Enfusion, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 15 June 2022 to 25 October 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 27 October 2022 with a share grant (€138k) in Enfusion, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen M. Dorton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,423 shares0Class A Common StockSEC:0001104659-22-112110:0
- 10,142 shares0Class A Common StockSEC:0001104659-22-072531:0
2 of 2 declarations